• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

What Amplitude’s direct listing says about IPO pops (and how startups can avoid them)

September 29, 2021 by David Barret Leave a Comment

As a general rule, I refuse to worry about how much money bankers make. They have historically done just fine, and I presume will continue to do so. In a similar manner, I don’t worry about how much money venture capitalists earn. Not really. Sure, it’s nice to figure out deal-specific returns here and there, but frankly, I care precisely not at all about any particular VC’s take-home.

But today we have to care a little bit about both, because we need to talk about direct listings, IPOs and how to price private companies. Yes, we’re talking about Amplitude’s recent public-market debut.


The Exchange explores startups, markets and money.

Read it every morning on Extra Crunch or get The Exchange newsletter every Saturday.


What follows is a dive into the IPO pricing issue and how startups are looking to get around the matter through alternative listing mechanisms. We’ll close with notes from an interview with Amplitude CEO Spenser Skates about the same matter. If you care about the value of private companies and how they are priced, this is for you. If you do not, please read anything else; you are going to be bored out of your socks.

Let’s go!

The problem with IPOs

Earlier this week, we asked if direct listings would be able to solve the IPO pricing issue. Or, more simply: Could direct listings coupled to last-minute private-market fundraising help startups dodge first-day IPO pops?

An IPO pop is what happens when a company prices its initial public offering at a lower price point than where it begins to trade. A little pop is generally considered healthy. A large pop is considered an error.

In more concrete terms, if a company prices at $45 per share in an IPO and kicks off its trading life worth $46, good job. Hell, even $48 would be uncontroversial. But when a company prices at $30 and opens at $45, it doesn’t matter if its shares later come back to Earth. A sin has been committed, at least in the eyes of the company and its private-market backers.

There are two issues with IPO pops that annoy startups and their investors:

  • First, they imply that the debuting company could have raised more money, or the same amount of capital, with less dilution. That makes sense.
  • Second, private companies and their partial owners (VCs) do not like it when free money is handed out to others, as when bankers price an IPO too low while securing fat allocation in the deal for their own customers; watching bankers that just showed up distribute upside for little work irks founders (reasonable) and venture investors (less reasonable).

The IPO pop issue has become more acute in recent years as some big-ticket public offerings have posted insane first-day results, opening to trade or closing their first day as public companies worth far more than they were expected to be when compared to their formal public-offering price.

One way to dodge an IPO pop is to direct list. In a direct listing, a company simply begins to trade. A reference price is set, but that’s largely a made-up number that folks ignore. It doesn’t matter much. And because the company in question isn’t setting a formal price for itself, it cannot suffer from a mispriced IPO. Huzzah; we’ve solved the problem.

Except we haven’t. IPOs have some good elements to them that everyone can agree on, chief of which is that they raise primary capital. By that we mean the company looking to list its shares in a traditional manner sells stock in the transaction. That’s why it has to set a price; it has to name a number at which it sells primary equity in its IPO.

With a direct listing, you do away with the pricing matter altogether, but it can be a bit baby-with-the-bathwater if a company wants to also raise capital to fund its operations, growth or whatever else. So, unicorns have come up with a neat compromise that appears to be a fix: raise a huge, final private round of capital and then quickly direct list. Doing so decouples pricing the company and it starting to trade.

Amplitude did just that earlier this week. It raised a multi-part close Series F at $32.0199 per share a few months back — and then direct listed.

However, there are issues.

Source Link What Amplitude’s direct listing says about IPO pops (and how startups can avoid them)

David Barret
David Barret

Related posts:

  1. Apple M1X MacBook Pro might drop as early as October
  2. White House vows to keep gasoline flowing as U.S. energy firms work to shake off Ida’s toll
  3. Monte dei Paschi prepares to close 50 branches – letter to unions
  4. Billions blown as Macau casino investors fold amid gambling review

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • First Visible Time Crystals Ever Made Have Astonishing Complexity And Practical Potential
  • “Something Undeniably Special”: The Chi Cygnids, A New Five-Yearly Meteor Shower, Peak This Month
  • A 200-Meter-Tall Event We Didn’t See Sent Signals Through The Earth For Nine Whole Days
  • Why Are So Many Volcanoes Underwater?
  • In 1977, A Hybrid Was Born In A Zoo. What It Taught Us Could Save One Of The Planet’s Most Endangered Species
  • How To Park A Dangerous Asteroid So It Doesn’t Bite You Later
  • New Study Finds Evidence For What Every Parent Knows About Bluey
  • New Breakthrough Takes Plastic Garbage And Turns It Into Tool For Carbon Capture
  • NASA To Hold Press Conference About New Perseverance Rover Discovery Tomorrow
  • Strange Halos Have Formed Around Barrels Of Chemicals Dumped Off LA’s Coast Over 50 Years Ago
  • As We Grow Older, Our Music Taste Appears To Narrow To Fewer Songs
  • Stinky Seaweed Blob On Florida Beaches Thwarts Baby Sea Turtles’ Dash To The Ocean
  • NASA Is Set To Lock Up Four Volunteers For 378-Day Mars Simulation Study
  • For The First Time, A Vital Oceanic Upwelling Of Nutrient-Rich Water Failed To Emerge In 2025
  • One Of The Largest Crocs Ever “Terrorized Dinosaurs” With Teeth The Size Of Bananas
  • US Congress Is Holding Another UFO Hearing Today – Watch Live
  • Yes, Flying Snakes Do Exist – Sort Of
  • Meet The Bumblebee Bat: The World’s Smallest Bat Is The Last Of Its Kind
  • Did A Giant Planet Sculpt Fomalhaut’s Stunning Ring Into Its Squashed Shape?
  • The Unfolding New Astronomical Revolution – Gravitational Waves Discovery Turns 10
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version